Data / Drug companies / MSN Laboratories Private Limited
MSN Laboratories Private Limited: 149 products in the FDA NDC directory, labeler code 54893
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
MSN Laboratories Private Limited (labeler code 54893) lists 149 products in the FDA National Drug Code Directory. By type: 149 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 8, 2026.
The request: Watch MSN Laboratories Private Limited (FDA labeler code 54893): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 54893
- Products in commercial distribution
- 149
- Packages
- 156
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 8
- Earliest marketing start
- March 16, 2001
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 149 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 149 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 146 | 98% |
| Oil | 3 | 2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Adagrasib | 54893-0525 | Powder | Bulk ingredients | September 8, 2026 |
| Levothyroxine | 54893-0131 | Powder | Bulk ingredients | July 18, 2026 |
| Fruquitinib | 54893-0524 | Powder | Bulk ingredients | March 30, 2026 |
| Selumetinib sulfate | 54893-0523 | Powder | Bulk ingredients | March 28, 2026 |
| Pirtobrutinib | 54893-0522 | Powder | Bulk ingredients | March 24, 2026 |
| Deucravacitinib | 54893-0521 | Powder | Bulk ingredients | March 24, 2026 |
| Methotrexate | 54893-0520 | Powder | Bulk ingredients | January 9, 2026 |
| Niraparib tosylate | 54893-0516 | Powder | Bulk ingredients | December 26, 2025 |
| Methotrexate sodium | 54893-0518 | Powder | Bulk ingredients | November 1, 2025 |
| Asciminib hydrochloride | 54893-0517 | Powder | Bulk ingredients | July 18, 2025 |
| Cabozantinib | 54893-0130 | Powder | Bulk ingredients | June 25, 2025 |
| Neratinib | 54893-0129 | Powder | Bulk ingredients | June 25, 2025 |
| Varenicline tartrate | 54893-0514 | Powder | Bulk ingredients | March 27, 2025 |
| Belzutifan | 54893-0515 | Powder | Bulk ingredients | March 26, 2025 |
| Vismodegib | 54893-0513 | Powder | Bulk ingredients | February 28, 2025 |
| Apalutamide (premix) | 54893-0128 | Powder | Bulk ingredients | January 20, 2025 |
| Cabozantinib fumarate | 54893-0512 | Powder | Bulk ingredients | September 30, 2024 |
| Relugolix | 54893-0511 | Powder | Bulk ingredients | September 26, 2024 |
| Sorafenib | 54893-0127 | Powder | Bulk ingredients | May 29, 2024 |
| Ruxolitinib hemifumarate | 54893-0509 | Powder | Bulk ingredients | March 28, 2024 |
| Lurbinectedin | 54893-0508 | Powder | Bulk ingredients | March 28, 2024 |
| Acalabrutinib maleate | 54893-0507 | Powder | Bulk ingredients | March 28, 2024 |
| Zanubrutinib (form-a) | 54893-0510 | Powder | Bulk ingredients | March 27, 2024 |
| Everolimus | 54893-0126 | Powder | Bulk ingredients | March 26, 2024 |
| Tucatinib hemiethanolate | 54893-0506 | Powder | Bulk ingredients | February 1, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.